Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Thyroid : Official Journal of the American Thyroid Association|July 3, 2015
Evaluating Positron Emission Tomography Use in Differentiated Thyroid CancerJaime L Wiebel, Nazanene H Esfandiari, Maria Papaleontiou, et al.
Cancer|January 8, 2015
Trends in imaging after diagnosis of thyroid cancerJaime L Wiebel, Mousumi Banerjee, Daniel G Muenz, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2014
Conditional survival in patients with thyroid cancerMousumi Banerjee, Daniel G Muenz, Francis P Worden, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 27, 2014
Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromesKanakadurga Singer, Nicholas Heiniger, Inas Thomas, et al.
Clinical Nuclear Medicine|July 18, 2018
Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid CancerPoorni M Manohar, Lauren J Beesley, Emily L Bellile, et al.
Cancer|October 20, 2020
Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteriaPaul L Swiecicki, Emily L Bellile, Collin V Brummel, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 2, 2011
Mebendazole monotherapy and long-term disease control in metastatic adrenocortical carcinomaIrina Y Dobrosotskaya, Gary D Hammer, David E Schteingart, et al.
Oncology Nursing Forum|September 7, 2013
Outcomes evaluation of a weekly nurse practitioner-managed symptom management clinic for patients with head and neck cancer treated with chemoradiotherapyHeidi Mason, Mary Beth DeRubeis, Jared C Foster, et al.
Investigational New Drugs|January 26, 2020
A multi-center phase II trial evaluating the efficacy of palbociclib in combination with carboplatin for the treatment of unresectable recurrent or metastatic head and neck squamous cell carcinomaPaul L Swiecicki, Greg Durm, Emily Bellile, et al.
Advances in Therapy|March 2, 2019
Real-World Treatment Patterns Among Patients Initiating Small Molecule Kinase Inhibitor Therapies for Thyroid Cancer in the United StatesStacey A Dacosta Byfield, Oluwakayode Adejoro, Ronda Copher, et al.
Pageof 14